Brookstone Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $534K | Sell |
10,054
-535
| -5% | -$28.4K | 0.01% | 725 |
|
|
2025
Q1 | $458K | Buy |
10,589
+713
| +7% | +$30.9K | 0.01% | 735 |
|
|
2024
Q4 | $555K | Sell |
9,876
-5,077
| -34% | -$285K | 0.01% | 662 |
|
|
2024
Q3 | $1.02M | Buy |
14,953
+2,147
| +17% | +$146K | 0.02% | 515 |
|
|
2024
Q2 | $632K | Buy |
12,806
+7,201
| +128% | +$356K | 0.01% | 594 |
|
|
2024
Q1 | $387K | Buy |
+5,605
| New | +$387K | 0.01% | 690 |
|
|
2023
Q3 | – | Sell |
-2,780
| Closed | -$252K | – | 845 |
|
|
2023
Q2 | $252K | Buy |
+2,780
| New | +$252K | 0.01% | 738 |
|
|
2021
Q4 | – | Sell |
-2,511
| Closed | -$244K | – | 746 |
|
|
2021
Q3 | $244K | Sell |
2,511
-11
| -0.4% | -$1.07K | ﹤0.01% | 652 |
|
|
2021
Q2 | $289K | Buy |
+2,522
| New | +$289K | 0.01% | 598 |
|